Nicotine metabolism and addiction among adolescent smokers

Addiction

Volumn 108, Issue 2, 2013, Pages 406-412

  Rubinstein, Mark L ^a   Shiffman, Saul ^b   Moscicki, Anna Barbara ^a   Rait, Michelle A ^a   Sen, Saunak ^c   Benowitz, Neal L ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d University of California   (United States)

Author keywords

Adolescent addiction; Adolescent smoking; Nicotine addiction; Nicotine metabolism; Nicotine metabolite ratio; Teen smoking

Indexed keywords

COTININE; DEUTERIUM; HYDROXYCOTININE; DIAGNOSTIC AGENT; DRUG DERIVATIVE;

ADDICTION; ADOLESCENT; ANALOGS AND DERIVATIVES; CHEMISTRY; DIAGNOSTIC USE; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MALE; METABOLISM; PROCEDURES; PROSPECTIVE STUDY; SALIVA; SELF REPORT; SMOKING; TANDEM MASS SPECTROMETRY; TOBACCO DEPENDENCE; ARTICLE; METHODOLOGY;

ADOLESCENT; BEHAVIOR, ADDICTIVE; CHROMATOGRAPHY, LIQUID; COTININE; DEUTERIUM; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; SALIVA; SELF REPORT; SMOKING; TANDEM MASS SPECTROMETRY; TOBACCO USE DISORDER;

EID: 84872611015     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2012.04026.x     Document Type: Article

References (44)

1. Substance Abuse and Mental Health Services Administration (SAMHSA). Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings. Office of Applied Studies, NSDUH Series H-38A, HHS Publication no. SMA 10-4856Findings. Rockville, MD: HHS Publications; 2010.
2. Sullivan P. F., Kendler K. S. The genetic epidemiology of smoking. Nicotine Tob Res 1999; 1: S51-57; discussion S69-70.
3. Benowitz N. L. Nicotine addiction. Prim Care 1999; 26: 611-631.
4. Benowitz N. L., Jacob P. III. Nicotine renal excretion rate influences nicotine intake during cigarette smoking. J Pharmacol Exp Ther 1985; 234: 153-155.
5. Benowitz N. L. Compensatory smoking of low-yield cigarettes. Paper presented at the Risks Associated with Smoking Cigarettes with Low Machine-Measured Yields of Tar and Nicotine, Bethesda, MD, 2001.
6. Pianezza M. L., Sellers E. M., Tyndale R. F. Nicotine metabolism defect reduces smoking. Nature 1998; 393: 750.
7. Schoedel K. A., Hoffmann E. B., Rao Y., Sellers E. M., Tyndale R. F. Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians. Pharmacogenetics 2004; 14: 615-626.
8. Gu D. F., Hinks L. J., Morton N. E., Day I. N. The use of long PCR to confirm three common alleles at the CYP2A6 locus and the relationship between genotype and smoking habit. Ann Hum Genet 2000; 64: 383-390.
9. Benowitz N. L. Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. Clin Pharmacol Ther 2008; 83: 531-541.
10. Berlin I., Gasior M. J., Moolchan E. T. Sex-based and hormonal contraception effects on the metabolism of nicotine among adolescent tobacco-dependent smokers. Nicotine Tob Res 2007; 9: 493-498.
11. Lea R. A., Dickson S., Benowitz N. L. Within-subject variation of the salivary 3HC/COT ratio in regular daily smokers: prospects for estimating CYP2A6 enzyme activity in large-scale surveys of nicotine metabolic rate. J Anal Toxicol 2006; 30: 386-389.
12. Malaiyandi V., Goodz S. D., Sellers E. M., Tyndale R. F. CYP2A6 genotype, phenotype, and the use of nicotine metabolites as biomarkers during ad libitum smoking. Cancer Epidemiol Biomarkers Prev 2006; 15: 1812-1819.
13. Audrain-McGovern J., Al Koudsi N., Rodriguez D., Wileyto E. P., Shields P. G., Tyndale R. F. The role of CYP2A6 in the emergence of nicotine dependence in adolescents. Pediatrics 2007; 119: e264-274.
14. O'Loughlin J., Paradis G., Kim W. etal. Genetically decreased CYP2A6 and the risk of tobacco dependence: a prospective study of novice smokers. Tob Control 2004; 13: 422-428.
15. Rubinstein M. L., Benowitz N. L., Auerback G. M., Moscicki A. B. Rate of nicotine metabolism and withdrawal symptoms in adolescent light smokers. Pediatrics 2008; 122: e643-647.
16. Moolchan E. T., Franken F. H., Jaszyna-Gasior M. Adolescent nicotine metabolism: ethnoracial differences among dependent smokers. Ethn Dis 2006; 16: 239-243.
17. Moolchan E. T., Parzynski C. S., Jaszyna-Gasior M. etal. A link between adolescent nicotine metabolism and smoking topography. Cancer Epidemiol Biomarkers Prev 2009; 18: 1578-1583.
18. Koudsi N. A., O'Loughlin J., Rodriguez D., Audrain-McGovern J., Tyndale R. F. The genetic aspects of nicotine metabolism and their impact on adolescent nicotine dependence. J Pediatr Biochem 2010; 1: 105-123.
19. Huang S., Cook D. G., Hinks L. J. etal. CYP2A6, MAOA, DBH, DRD4, and 5HT2A genotypes, smoking behaviour and cotinine levels in 1518 UK adolescents. Pharmacogenet Genomics 2005; 15: 839-850.
20. Malaiyandi V., Sellers E. M., Tyndale R. F. Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence. Clin Pharmacol Ther 2005; 77: 145-158.
21. Hukkanen J., Jacob P. III, Benowitz N. L. Metabolism and disposition kinetics of nicotine. Pharmacol Rev 2005; 57: 79-115.
22. Mwenifumbo J. C., Tyndale R. F. Genetic variability in CYP2A6 and the pharmacokinetics of nicotine. Pharmacogenomics 2007; 8: 1385-1402.
23. Benowitz N. L., Hukkanen J., Jacob P. III. Nicotine chemistry, metabolism, kinetics and biomarkers. Handb Exp Pharmacol 2009; 192: 29-60.
24. Benowitz N. L., Lessov-Schlaggar C. N., Swan G. E., Jacob P. III. Female sex and oral contraceptive use accelerate nicotine metabolism. Clin Pharmacol Ther 2006; 79: 480-488.
25. Messina E. S., Tyndale R. F., Sellers E. M. A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes. J Pharmacol Exp Ther 1997; 282: 1608-1614.
26. Nakajima M., Yamamoto T., Nunoya K. etal. Role of human cytochrome P4502A6 in C-oxidation of nicotine. Drug Metab Dispos 1996; 24: 1212-1217.
27. Dempsey D., Tutka P., Jacob P. III etal. Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity. Clin Pharmacol Ther 2004; 76: 64-72.
28. Benowitz N. L., Pomerleau O. F., Pomerleau C. S., Jacob P. III. Nicotine metabolite ratio as a predictor of cigarette consumption. Nicotine Tob Res 2003; 5: 621-624.
29. Prokhorov A. V., De Moor C., Pallonen U. E. etal. Validation of the modified Fagerström Tolerance Questionnaire with salivary cotinine among adolescents. Addict Behav 2000; 25: 429-433.
30. Jacob P. III, Benowitz N. L., Shulgin A. Synthesis of optically pure deuterium-labelled nicotine, nornicotine and cotinine. J Label Compd Radiopharm 1988; 25: 1117-1128.
31. Benowitz N. L., Jacob P. III. Metabolism of nicotine to cotinine studied by a dual stable isotope method. Clin Pharmacol Ther 1994; 56: 483-493.
32. Jacob P. III, Yu L., Duan M. etal. Determination of the nicotine metabolites cotinine and trans-3′-hydroxycotinine in biologic fluids of smokers and non-smokers using liquid chromatography-tandem mass spectrometry: biomarkers for tobacco smoke exposure and for phenotyping cytochrome P450 2A6 activity. J Chromatogr B Analyt Technol Biomed Life Sci 2011; 879: 267-276.
33. Johnstone E., Benowitz N., Cargill A. etal. Determinants of the rate of nicotine metabolism and effects on smoking behavior. Clin Pharmacol Ther 2006; 80: 319-330.
34. Lerman C., Tyndale R., Patterson F. etal. Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation. Clin Pharmacol Ther 2006; 79: 600-608.
35. Benowitz N. L., Perez-Stable E. J., Herrera B., Jacob P. III. Slower metabolism and reduced intake of nicotine from cigarette smoking in Chinese-Americans. J Natl Cancer Inst 2002; 94: 108-115.
36. Shiffman S., Ferguson S. G., Dunbar M. S., Scholl S. Tobacco dependence among intermittent smokers. Nicotine Tob Res 2012. doi: 10.1093/ntr/nts097.
37. Shiffman S., Sayette M. A. Validation of the nicotine dependence syndrome scale (NDSS): a criterion-group design contrasting chippers and regular smokers. Drug Alcohol Depend 2005; 79: 45-52.
38. Leong J. W., Dore N. D., Shelley K. etal. The elimination half-life of urinary cotinine in children of tobacco-smoking mothers. Pulm Pharmacol Ther 1998; 11: 287-290.
39. Dempsey D., Jacob P. III, Benowitz N. L. Nicotine metabolism and elimination kinetics in newborns. Clin Pharmacol Ther 2000; 67: 458-465.
40. Rubinstein M. L., Luks T. L., Moscicki A. B. etal. Smoking-related cue-induced brain activation in adolescent light smokers. J Adolesc Health 2011; 48: 7-12.
41. Nestler E. J. Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2001; 2: 119-128.
42. Trauth J. A., Seidler F. J., Ali S. F., Slotkin T. A. Adolescent nicotine exposure produces immediate and long-term changes in CNS noradrenergic and dopaminergic function. Brain Res 2001; 892: 269-280.
43. Trauth J. A., Seidler F. J., McCook E. C., Slotkin T. A. Adolescent nicotine exposure causes persistent upregulation of nicotinic cholinergic receptors in rat brain regions. Brain Res 1999; 851: 9-19.
44. DiFranza J. R., Rigotti N. A., McNeill A. D. etal. Initial symptoms of nicotine dependence in adolescents. Tob Control 2000; 9: 313-319.